Ocrevus 920 mg solution for injection

Licence status
Authorised: 20/06/2024
Active substances
Ocrelizumab
Dosage Form
Solution for injection
Licence number
EU/1/17/1231/003
Licence holder
Roche Registration GmbH

Product documents

Licence information

ATC code
L04AG08 ocrelizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/06/2024